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ABSRACT
Failure to comply with drug regimes is prevalent amongst patients with epilepsy and the consequence of this is often an
increased risk of further seizures and other associated harms including increased health care costs. Contributing factors
leading to non-compliance of anti-epileptic drugs has not been examined in Pakistan. We investigated the factors influencing
non-compliance to prescribed antiepileptic drugs (AEDs). A cross-sectional study was employed for a total of 53 epileptic
patients with non-compliance of anti-epileptic drugs. The data-collection tools were a questionnaire and structured interview
for this study. Results showed that males were more liable to non-compliance of AEDs as compared to females. Medication
complexity (more than 2 antiepileptic drugs), treatment duration (>6 months) and elderly age (> 55 years) were the major
reasons of non-compliance. Further implementation of educational programmes for people with epilepsy would help to
improve levels of compliance thereby reducing the risk of unnecessary seizures.
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Introduction:

more is non-compliant whereas others feel that only those who
fail to comply more than occasionally, say at least 25% of the
time, should be classed as non-compliant.5 Non-compliance
to AEDs by epileptic patients has been reported to be high and
studies have demonstrated a higher prevalence of seizures
(21-45%) in those who did not comply to their AED
regimens.6,7 In addition, non-compliance to AEDs has been
reported to increase morbidity and mortality, as well as
decrease quality of life and productivity.9 Non-compliance was
also reported to be associated with reduced mental and
emotional wellbeing, including impaired cognition. Of the
world’s 50 million people with epilepsy, 85% live in developing
countries.1 However, few studies on compliance have been
performed in Asian and developing countries.5 However, none
of those was conducted in Pakistan in order to determine
prevalence of non-compliance and factors which lead to
non-compliance of AEDs in epileptic patients. We therefore
conducted this study on a sample of adult patients with
epilepsy to examine major factors associated with
non-compliance to AEDs.

Epilepsy is a common and widespread neurological disorder,
affecting people of all ages and socioeconomic classes
worldwide.1 Of those diagnosed with epilepsy, the vast majority
of such patients are advised with antiepileptic drugs (AEDs)
and approximately 70% may become seizure-free once the
most effective regime is followed.2 However, approximately
every third of patients with epilepsy continue to experience
seizures despite the prescription of appropriate doses of
AEDs.3 Poor compliance to AEDs may be the most important
cause of poorly controlled epilepsy. The term “compliance”
describes the extent to which a patient takes medications, as
prescribed with respect to dosage and dosing intervals.4
Non-compliance to treatment is widespread especially for
chronic disease and is considered to be a significant problem
faced by medical practice. Failing to comply increases the
likelihood of hospital admissions, thus there could be a
potential saving to the health care services if compliance could
be improved. The term non-compliance lists following aspects
in its definition: not taking the correct dosage (too much or too
little), failing to leave the recommended length of time
between doses, not taking medication for the duration
specified, taking other drugs not prescribed. Some physicians
believe that any patient who fails to adhere on one occasion or
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Services Hospital, Lahore, Pakistan. Male and female patients,
aged 10 to 70 years, who had been diagnosed with epilepsy
at least one year previously, were included in this 6-month
study which was originaly conducted in 1st July- 30th
December 2012. Patients who met the following criteria were
also invited to participate in this study: (1) therapy
recommended with at least one AED, irrespective of any
standard or non-standard treatment; (2) suspected or
reported non-compliance to AEDs and (3) no change in AEDs
in
the
last
six
months.
Patients
with
comorbidities(Diabetes,Ischemic heart disease) and those
who were not able to respond to an interview were excluded.
In this study, we included a total of 225 patients who were
having the primary diagnosis of Epilepsy. This number was
calculated statistically with help of software after taking 95%
confidence interval and 5% absolute precision. Out of these
225, 53 patients were reported to be non-compliance to
AEDs. A total of 53 patients reported with non-compliance to
AEDs were included in the present study. The patients were
arbitrarily divided into three age groups: an adolescent group
(10-30 years), an adult group (31-55 years), and an older
group (56-70 years). The data-collection tools were a
questionnaire which was completed through structured
interview. The patient survey comprised questions regarding
demographics (gender, age, etc.), seizure history (type and
frequency), current AED treatments, self-reported
non-compliance to AEDs, and the reasons of non-compliance.
The questionnaires were completed in the presence of parents
for children patients (< 15 years of age). For this study,
compliance was defined as not missing a dose and
non-compliance as missing a dose or stopping treatment in
the last month. The socio-economic status of the patients’
parents was determined using variables like area of residence
and monthly income. In this way, the subjects were
categorized into Low class if they had a monthly income < 15,
000 PKR; Middle class if monthly income was betwen
15,000-30,000; and High class if income was > 30,000.
Participants gave written informed consent after the purpose
of the study had been explained to them. The ethics
committee of the hospital approved the study.

agreed to participate in the study. The patients came from
different cities and towns of Lahore division. When epileptic
patients reported with non-compliance were divided into three
age groups, adult patients (31-55 years) represented the
largest age group (36% of all patients) followed by old patients
(34%) and adolecents (30%) (Figure 1).
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Figure 1. Age distribution of epileptic patients reported with
non-compliance of AEDs.
Of all patients with non-compliance, 33 (62.3%) were males
and 20 (37.7%) were females. The mean patient age (±SD)
was 46.9 (±5.3) years (range: 10-70 years) (Figure 2).
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Figure 2. Gender distribution of epileptic patients reported
with non-compliance of AEDs.

Statistical analyses
The descriptive statistical analysis included examinations of
means, standard deviations, frequencies, ranges, and
percentages. The statistical packages SPSS (Version 20) and
MS Excel (MS Office 2010) were used.

Three main factors were identified in this study which led to
non-compliance of AEDs in all 53 patients. Age factor,
Tretment duration and medication complexity were the main
reasons of non-compliance. Of the all the patients, the primary
reason was medication complexity. A total of 43.4% patients
did not comply to the AEDs treatment when the physician
advised more than two AEDs. This was the major reason of
non-compliance. Treatment duration was the second largest

Results
In total, 53 patients met all study inclusion criteria, and who
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reason attributing the patients towards non-compliance. Of all
the patients, 34% reported that they could not comply
because of treatment duration. Treatment duration greater
than 6 months was cut-off period beyond which there was
significant non-compliance to AEDs. Third reason of
non-compliance was age factor as it was reported by 22.6% of
the patients. Figure 1 clearly shows that non-compliance was
less frequent in younger population as it shows only 29% of
the patients. Elderly people specifically aged more than 31-55
years and 55-70 years could not comply to AEDs.

among all the patients of non-compliance, almost 68% were
single and only 32% were married.
Discussion
This is the one of the first studies which was carried out to
investigate the related factors of non-compliance to AEDs in
epilepsy patients in Pakistan. Compliance is difficult to
measure accurately. For epilepsy, compliance to medication
has previously been measured by self-reporting, drug blood
level monitoring, and prescription refill monitoring. Compliance
measured by self-reporting may be overestimated but is
considered to be the simplest and least expensive method. In
this study, major reasons of non-compliance were measured
by self-reporting. In our study, 23% of patients were
non-compliant to AEDs. This percentage was smaller than that
reported in other countries: Arab countries (64%), the United
States (29-58%), and the United Kingdom (59%).5,9,10In
our study, elderly patients aged more than 55 years had the
highest rates of non-compliance. This may be due to the fact
that elderly patients have more difficulty in following
instructions due to cognitive impairment or other physical
difficulties, such as problems in swallowing tablets, opening
drug containers, handling small tablets, distinguishing colours
or identifying markings on drugs.11 The duration of treatment
period was also a factor that affected non-compliance. In a
study of epilepsy patients, omission of dose was reported to be
more frequent with a longer duration of seizure medication
use.7 The long treatment duration might compromise patients’
beliefs about medication effectiveness. In our study, the one of
three factors that affected compliance was the duration of
treatment period. There were many factors that influenced
patients’ perception and beliefs with regards to
non-compliance because of longer duration of treatment.
Patients’ knowledge about their disease and treatment is not
always adequate and they may lack an understanding of the
role of therapy, be fearful of dependency on long-term
medication, lack knowledge about the disease and
consequences of non-compliance, and may assume that the
need for medication is intermittent and thus stop taking the
drug in order to see whether medication is still required.12,13

Factors of Non-compliance
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Figure 3. Frequency of factors contributing towards
non-compliance of AEDs in Epileptic patients
Socio-economic (education status, economic class) and
psychosocial factors like Beliefs (myths),Motivation, Attitude of
the patients were strongly correlated with the non-compliance
AEDs. Economic class of the patients was mae on the basis of
monthly income, type of profession and area of residence of
the patients. On this basis, patients were classified into Low
class (monthly income < 15000), Middle Class (monthly
income up to 25000) and High class (monthly income >
25000). Table 1 shows that non-compliance behavior was
presented mainly by patients belonging to low (35%) and
middle class (47%). Similarly non-compliance of AEDs was
greater in patients with lower education as 47% of the patients
were having only primary education. Another factor was the
marital status of the patients. Table 1 clearly shows that

Educational level (%)

Forgetfulness
(%)

Single Married

Psycosocial
factor
(%)
Yes No

Illetrate Elementary Matric Intermediate

Yes

No

67.9

68

15.1

49.2

50.8

Economic Class
(%)

Marital Status
(%)

Low Middle High
35

47

18

32.1

32

47.2

20.8

17

Table 1. Socio-economic and individual factors attributing to non-compliance AEDs in Epileptic patients.
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For these reasons, patient education is very important in order
to enhance compliance. A poor patient-prescriber relationship
is another strong factor which affects patient compliance;
good relationship may enhance compliance. In order to build
a healthy relationship, physicians should not only question
patients about seizure frequency and current medication use,
but also specifically probe them about compliance. They
should give patients a detailed explanation about the disease,
treatment regimens, the true side effects, and the importance
of compliance, and spend more time with the patients.13
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Conclusion
Medication compliance remains an important issue in epilepsy
treatment especially in developing countries. The
non-compliance of epilepsy patients is common in Pakistan as
well. Medication complexity (more than 2 antiepileptic drugs),
treatment duration (>6 months) and elderly age (> 55 years)
were major reasons of non-compliance. Targeted
management programs and communication strategies are
necessary to improve compliance to antiepileptic drug
treatment for patients with epilepsy and avoid the clinical
consequences of poor compliance.
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